BIOTECH VENTURE CAPITAL INFORMATION & STATS
Biotechnology private equity is critical to the success of companies within the field due to its capital-intensive nature and great need for research and development. Biotechnology venture capital companies usually provide funding to businesses in metropolitan areas due to the high potential for job and revenue growth. According to studies by PricewaterhouseCoopers, an estimated 18% of the $27.7 billion of US venture capital investments in 2007 went to biotech companies. Biotechnology venture capital firms typically play a key role in these companies during the seed stage venture capital and expansion stages, and normally provide funding amounts ranging from $500,000 to $6 million. The need for biotech financing on a worldwide basis is continuously growing hand-in-hand with technological changes.
If you are in need of biotech funding for research or expansion backing, get venture funding from FindVenture.com and get connected with some of the top biotech venture capital firms in diverse regions based on your needs.
Featured Investors
Intersouth Ventures is a Durham, NC venture capital firm specializing in early and seed stage funding companies in life sciences and technology within the southeast region. Intersouth Ventures provides initial investments ranging from $500,000 to $6 million and up to $12 million investment for companies in their portfolio.
MPM Capital is a venture capital company investing in life sciences businesses across the world with more than $2 billion in committed capital. MPM Capital usually focuses on companies in biotechnology, specialty pharmaceuticals, and medical technology through diverse funds, providing investments ranging from $5 million to $50 million.
Sorrento Ventures is a west coast private equity company targeting San Diego, California businesses in diverse industries, including biotechnology, medical devices, enterprise software, electronics, and hardware, with the potential to reach $50 million in annual revenue within five years. Sorrento Ventures has $115 million in capital under management, providing companies with $1 million to $2 million in initial investment and $5 million to $10 million in follow-on investments.
Seaflower Ventures is a Waltham, Massachusetts venture capital company dedicated to early stage and startup life sciences and medical technology businesses in North America, and specifically those within biotechnology, biopharmaceuticals, computational biology, e-pharma, and medical devices. Seaflower Ventures Inc. provides $1 million to $3 million in initial financing with up to $10 million in follow-on investment for companies within their portfolio.
Sanderling Ventures is one of the earliest players in biomedical venture capital since its launch in 1979. It has aided more than 90 companies from early stages to commercialization as well as later stage financing rounds. Focusing on emerging technologies in the biomedical field, Sanderling Ventures targets high-potential businesses specializing in biotechnology, therapeutics, pharmaceuticals, drug delivery, medical devices, imaging, diagnostics, medical informatics, and healthcare services.
ARCH Venture Partners currently has seven funds totaling $1.5 billion and supports companies within life sciences, IT, and physical sciences through seed and early stage funding. The firm originated in the midwest region, but has expanded to provide backing to companies on a nationwide basis with offices in Illinois, Texas, Washington, and California.
Forward Ventures is a life sciences and medical device investment company and represents one of the premiere west coast venture capital firms out there today. Based in California, they are searching for business dedicated to creating and commercializing treatments for diseases. Since its inception in 1993, Forward Ventures has invested in more than 50 companies and has $500 million in funds under management.
Domain Associates Llc has been providing private/public equity to life sciences companies, including pharmaceuticals, specialty pharmaceuticals, and medical devices, since 1985. With a total of $2.5 billion in funds under management, Domain Associates supports companies from early to public status alike in financing needs.
Abingworth Management Limited is an international investment company focused in life sciences and healthcare in the US and Europe. It currently has $1.25 billion in funders under management and supports companies in all stages including venture capital, growth financing, and public markets with average total investments ranging from $20 million to $80 million.
Versant Ventures is a venture capital firm with more than $1.6 billion in committed capital and specializes in investments for companies within healthcare services/IT, biotechnology, medical devices, and pharmaceuticals. Versant Ventures currently has a portfolio of 75 companies.
